Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
+655K
-
Total reported value, excl. options
-
$134M
-
Value change
-
+$4.87M
-
Number of buys
-
25
-
Number of sells
-
-19
-
Price
-
$7.20
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q4 2020
65 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q4 2020.
Apyx Medical Corp - Common Stock (APYX) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 35M outstanding shares and own 53.02% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.39M shares), Archon Capital Management LLC (2.5M shares), BlackRock Inc. (2.33M shares), VANGUARD GROUP INC (1.43M shares), PURA VIDA INVESTMENTS, LLC (903K shares), JPMORGAN CHASE & CO (641K shares), Taylor Frigon Capital Management LLC (621K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), STATE STREET CORP (580K shares), and ROYCE & ASSOCIATES LP (559K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.